Biocon informs about press release

09 Feb 2024 Evaluate
Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab.’ The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

369.10 1.75 (0.48%)
24-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.80
Dr. Reddys Lab 1259.60
Cipla 1219.30
Zydus Lifesciences 886.50
Lupin 2331.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×